… MALIGNANT hyperthermia (MH) occurs when a patient who has inherited a causative …
ambulatory surgery center (ASC) as in a medically complex inpatient. The Malignant Hyperthermia …

… SE of malignant hyperthermia due to anesthesia by surgical procedure category in ambulatory
surgery centers, … Clinical Classification Software is used to aggregate surgical procedure …

… trigger a potentially lethal malignant hyperthermia (MH) event requiring critical care crisis
management. If the MH triggering anesthetic is given in an ambulatory surgical center (ASC), …

Background The initial presentation of malignant hyperthermia (MH) may begin in the
postoperative period. However, the maximal latency period between the end of anesthesia care …

… surgery centers, skilled nursing facilities, and long-term care facilities; and routine
admissions, including physician referrals, outpatient or clinic referrals, and Health Maintenance …

… work in the surgical center during care for patients in crisis, the aim of this study is to assess
… knowledge of malignant hyperthermia among the nursing professionals in a surgical center. …

… Most frequently associated with orthopedic surgery, malignant hyperthermia is a rare genetic
… Although the number of deaths due to malignant hyperthermia has greatly declined in the …

… Manifestations of malignant hyperthermia (MH) are precipitated by certain volatile
anesthetics (ie, halothane, isoflurane, sevoflurane, desflurane, enflurane), either alone or in …

… The results of this analysis suggest that stocking dantrolene for the treatment of MH in
ambulatory surgery centers as recommended by the Malignant Hyperthermia Association of the …

… In the 70-ties, the mortality after a malignant hyperthermia crisis was 64% [7]. Thanks to
the introduction of dantrolene and advances in intraoperative monitoring techniques, the …